top of page
Editorial
Search
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecifi
Jul 26, 20214 min read
 
 
 


Suvoda wraps up first half of 2021 with strong business growth, geographical expansion, and new prod
Jul 26, 20212 min read
 
 
 


Jul 26, 20213 min read
 
 
 


Jul 26, 20212 min read
 
 
 
Jul 26, 20212 min read
 
 
 
Jul 26, 20211 min read
 
 
 
Jul 26, 20212 min read
 
 
 
Jul 26, 20212 min read
 
 
 


Jul 26, 20215 min read
 
 
 
Jul 26, 20212 min read
 
 
 
Jul 26, 20212 min read
 
 
 
Jul 26, 20213 min read
 
 
 
Jul 26, 20215 min read
 
 
 
Jul 26, 20211 min read
 
 
 
Jul 26, 20212 min read
 
 
 
Jul 26, 20211 min read
 
 
 
Jul 26, 20211 min read
 
 
 
Jul 26, 20212 min read
 
 
 
Jul 25, 20211 min read
 
 
 


Jul 25, 20211 min read
 
 
 
Jul 25, 20211 min read
 
 
 


Jul 25, 20211 min read
 
 
 
Jul 25, 20211 min read
 
 
 


Jul 25, 20213 min read
 
 
 
bottom of page


